Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1020 (LINC01020) is a lincRNA gene found in the human genome. lincRNAs are a subclass of long non-coding RNAs (lncRNAs) that are transcribed from intergenic regions, meaning they do not overlap protein-coding sequences. These RNAs are typically longer than 200 nucleotides and participate in a range of regulatory processes including chromatin modification, transcriptional regulation, and fine-tuning of gene expression often with tissue specificity. While lincRNAs as a group have been implicated in cancer, developmental biology, and other diseases, there is currently no strong evidence that LINC01020 specifically is involved in any particular disease, nor is it a recognized therapeutic target. Only a very small subset of lincRNAs have been mechanistically or clinically characterized in detail[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1020 (LINC01020).